IgGenix emerges from stealth with $10 million Series A hoping to re-engineer allergic cascade

Retrieved on: 2020-08-03 19:26:15

Tags for this article:

Click the tags to see associated articles and topics

IgGenix emerges from stealth with $10 million Series A hoping to re-engineer allergic cascade. View article details on hiswai:

Excerpt

<div>Financing was led by <b>Khosla Ventures</b> and joined by Parker Ventures. When an allergic reaction occurs, the body produces an excessive amount of ...</div>

Article found on:

View Original Article